tiprankstipranks
HTG Molecular Diagnostics (HTGMQ)
OTHER OTC:HTGMQ
US Market
Want to see HTGMQ full AI Analyst Report?

HTG Molecular Diagnostics (HTGMQ) Income Statement

458 Followers

HTG Molecular Diagnostics Income Statement

Last quarter (Q1 2023), HTG Molecular Diagnostics's total revenue was $1.03M, a decrease of -12.83% from the same quarter last year. In Q1, HTG Molecular Diagnostics's net income was $-5.05M. See HTG Molecular Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 6.37M$ 8.91M$ 8.55M$ 19.20M$ 21.50M
Gross Profit
$ 1.79M$ 4.81M$ 4.56M$ 10.29M$ 16.41M
Operating Expenses
$ 22.62M$ 22.64M$ 24.56M$ 29.25M$ 32.57M
Depreciation and Amortization
$ 587.14K$ 721.25K$ 1.35M$ 1.26M$ 1.47M
EBITDA
$ -20.14M$ -15.36M$ -18.48M$ -17.08M$ -14.08M
Operating Income
$ -20.83M$ -17.82M$ -19.59M$ -18.96M$ -16.16M
Other Income/Expenses
$ -754.04K$ 701.13K$ -1.27M$ -334.18K$ -291.16K
Pretax Income
$ -21.58M$ -17.12M$ -20.86M$ -19.29M$ -16.45M
Net Income
$ -21.59M$ -17.15M$ -20.87M$ -19.30M$ -16.45M
Per Share Metrics
Basic EPS
$ -24.28$ -29.66$ -54.12$ -91.17$ -107.61
Diluted EPS
$ -24.28$ -29.66$ -54.12$ -91.17$ -107.61
Weighted Average Shares Outstanding
889.28K 578.01K 385.66K 211.66K 152.91K
Weighted Average Shares Outstanding (Diluted)
889.28K 578.01K 385.66K 211.66K 152.91K
Currency in USD

HTG Molecular Diagnostics Earnings and Revenue History